Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MARAVAI LIFESCIENCES HOLDINGS, INC. | President, Nucleic Acid Production | Class A Common Stock | 422K | $2.4M | $5.70 | Apr 30, 2024 | Direct |
MARAVAI LIFESCIENCES HOLDINGS, INC. | President, Nucleic Acid Production | Employee Stock Options (Right to Buy) | 80K | Apr 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Apr 30, 2024 | 1 | $9.8K | 4 | May 2, 2024 | President, Nucleic Acid Production |
MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Apr 15, 2024 | 1 | -$136K | 4 | Apr 16, 2024 | President, Nucleic Acid Production |
MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Jan 16, 2024 | 1 | $0 | 4 | Jan 18, 2024 | President, Nucleic Acid Production |
MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dec 31, 2023 | 2 | $0 | 5 | Jan 18, 2024 | President, Nucleic Acid Production |
MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Mar 31, 2023 | 0 | $0 | 3 | Apr 6, 2023 | Executive Vice President and General Manager, Nucleic Acid Products Exhibit 24.1 - Power of Attorney |